FinTrust Capital Advisors’s Core Laboratories CLB Stock Holding History

FinTrust Capital Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-103	Closed	-$2.47K	–	1269
2023 Q3	$2.47K	Sell	103 -155	-60%	-$3.8K	﹤0.01%	988
2023 Q2	$5.23K	Hold	258	–	–	﹤0.01%	866
2023 Q1	$5.23K	Hold	258	–	–	﹤0.01%	860
2022 Q4	$5.23K	Hold	258	–	–	﹤0.01%	858
2022 Q3	$4K	Buy	258 +72	+39%	+$1.21K	﹤0.01%	1038
2022 Q2	$3K	Buy	+186	New	+$4.94K	﹤0.01%	1084
2021 Q3	–	Sell	-71	Closed	-$3K	–	1160
2021 Q2	$3K	Buy	+71	New	+$2.54K	﹤0.01%	1084
2019 Q2	–	Sell	-36	Closed	-$2K	–	1087
2019 Q1	$2K	Hold	36	–	–	﹤0.01%	1082
2018 Q4	$2K	Buy	+36	New	+$3.11K	﹤0.01%	1082

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FinTrust Capital Advisors's CLB Position: Q4 2023 in Review

FinTrust Capital Advisors sold out of Core Laboratories (CLB) in Q4 2023, closing a stake of 103 shares — an estimated $2.47K sold.

FinTrust Capital Advisors first reported a position in CLB in Q4 2018 and held it in 9 quarters. The position peaked at $5.23K in Q2 2023. 186 funds tracked by Wall St. Rank hold CLB as of Q4 2023.

FinTrust Capital Advisors reported no remaining Core Laboratories position as of Q4 2023 after selling out during the quarter.
FinTrust Capital Advisors sold 103 Core Laboratories shares in Q4 2023, an estimated $2.47K.
FinTrust Capital Advisors first reported a position in Core Laboratories in Q4 2018 and held it in 9 quarters.
FinTrust Capital Advisors's Core Laboratories position peaked at $5.23K in Q2 2023.
186 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2023.

Based on FinTrust Capital Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.